3 2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change Introduction While the pandemic challenged the way every business operates, at BD, it pushed us to evolve to be more agile and efficient, using our scale and speed to create more innovative solutions faster than ever before. And now, we’re strengthening those muscles so we remain agile in the future and continue to deliver on our ambitious plans to accelerate the future of healthcare for decades to come. As we look ahead, we’re using that same mindset as we take action to address the most relevant environmental, social and governance (ESG) issues. We’ve made commitments that build on our Purpose of advancing the world of health TM and focus on enhancing the stewardship of our company, planet, community and human health. True to our culture, we’re delivering on these commitments today. Together we advance We have strong momentum behind our BD 2025 strategy, which focuses on three pillars: GROW through category innovations that improve customer outcomes and reinvent the future of healthcare globally; SIMPLIFY the company and how we do business; and EMPOWER our people. Centered around our durable core and transformative solutions, our portfolio delivers reliable products and solutions that serve as the backbone of healthcare, and new innovations that are advancing three irreversible forces changing the future of healthcare: smart connected care, the shift to alternative care settings and improving chronic disease outcomes. Integral to our success is our deep commitment to improving individual and public health at a global scale. In early FY22, we launched our 2030+ ESG strategy, Together We Advance, which serves as a framework to address some of the most relevant ESG issues for our business and our stakeholders. To our stakeholders We’ve made commitments in five areas where we see the most opportunity to create meaningful change over the next decade: climate change, product impact, a responsible supply chain, a healthy workforce and community, and transparency. Our report details each area, our accomplishments and the steps we are taking on this journey. Our performance Environment We recognize the impact of climate change on human health around the world, and as a healthcare company, we’re committed to reducing our own impact. As a result, we committed to the UN Race to Zero and the Science Based Targets initiative (SBTi) in September. We’ve made progress aligned with our established targets to reduce our Scope 1 and 2 greenhouse gas (GHG) emissions, and we continue to work on setting science-based targets for Scope 3. By minimizing energy demand, we’ve achieved a 14 percent reduction and continued to increase our investment in on-site renewable energy. Currently, 13 BD locations obtain 100 percent of their electric power from renewable sources. Product impact Our newly formed BD Sustainable Medical Technology Institute will guide us in reducing the environmental impact of our portfolio, setting sustainable design standards for our products and identifying more sustainable sterilization technologies. We also established the BD Product Impact Council to support and track progress toward achieving our 2030+ product impact goals. Throughout our 125-year history as one of the largest global medical technology companies, we’ve used our capabilities, expertise and scale to address critical healthcare needs for people around the world. Time and time again, BD has stepped up to make a difference by innovating faster to deliver critical products and solutions that save lives. We’ve done this to help patients no matter where they are in their healthcare journey—getting routine checks or battling chronic illness—and we’ve done this on a large, global scale to combat some of the world’s biggest health crises like polio, HIV and more recently COVID-19. Chairman, CEO and President Tom Polen